Compare BNTC & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | ELLO |
|---|---|---|
| Founded | 1995 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.0M | 392.7M |
| IPO Year | 2020 | 1998 |
| Metric | BNTC | ELLO |
|---|---|---|
| Price | $10.48 | $24.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | ★ 120.5K | 2.1K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $13.00 |
| 52 Week High | $17.15 | $30.34 |
| Indicator | BNTC | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 44.80 |
| Support Level | $10.10 | $24.45 |
| Resistance Level | $14.13 | $29.40 |
| Average True Range (ATR) | 0.72 | 0.95 |
| MACD | 0.01 | -0.43 |
| Stochastic Oscillator | 38.80 | 21.07 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.